MDS-PAS Pediatric Movement Disorders Course

Introduction

MDS-PAS Pediatric Movement Disorders Course

Course Format

In-Person

Start Date

Fri, Jun 6, 2025

End Date

Sun, Jun 8, 2025

Course Location

Boston, Massachusetts

Program Description

The MDS-PAS Pediatric Movement Disorders Course will provide a state-of-the-art review of current practices, controversies, and active areas of research in pediatric movement disorders. This program will bring together the pediatric movement disorders community to discuss topics pertinent to specialists, neurologists, researchers, and clinicians from adjacent fields of neurosurgery and genetics.

REGISTRATION DEADLINE: May 23, 2025

This course is nearing capacity for in-person attendance. Please contact the MDS Secretariat at education@movementdisorders.org to inquire about registration. This course is also available to stream online. To register for virtual attendance, please visit: https://education.movementdisorders.org/Detail/949/MDS-PAS-Pediatric-Movement-Disorders-Course-VIRTUAL-LIVE-STREAM

Course Location

Boston, Massachusetts USA
Click here to view location map

Contact Us

MDS Education
education@movementdisorders.org

Course Overview (Course Overview, Agenda, & Fees)

Course Schedule Course Faculty

Schedule as of April 30, 2025

Abstract Submission Deadline: May 9, 2025
Video Case Submission Deadline: May 9, 2025

REGISTRATION FEES
Members: $250 USD
Members: Junior / HP / Basic Science / No Fee: $125 USD
Non-Members*: $450 USD

*Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of the close of registration.

Click here to view the MDS Regional Course Cancellation Policy & Visa Assistance Information

COURSE VENUE

Venue Name: 201 Brookline

Address: 201 Brookline Ave, Boston, MA 02215

LEARNING OBJECTIVES

Upon completion of this activity, learners will be able to:

1. Develop a framework for the application of deep brain stimulation in the treatment of status dystonicus, cerebral palsy, and hyperkinetic movement disorders

2. Define emerging disease-modifying therapies for genetic movement disorders

3. Summarize the current approach to managing status dystonicus and other movement disorder emergencies in children

4. Describe the expanding molecular and clinical spectrum of epilepsy-dyskinesia syndromes

5. Develop an approach to palliative care for progressive movement disorders and transition of care from pediatric to adult neurology

INTENDED AUDIENCE

This activity is intended for for clinicians, fellows, residents, students, researchers, and health professionals.

To register for the virtual live stream course, please visit: https://education.movementdisorders.org/Detail/949/MDS-PAS-Pediatric-Movement-Disorders-Course-VIRTUAL-LIVE-STREAM

Commercial Support Acknowledgement

Exhibitor Acknowledgement

The MDS-PAS Pediatric Movement Disorder Course wishes to acknowledge the following exhibitors:

Abbott

AbbVie

Bow Foundation

Dystonia Medical Research Foundation

Lilly & Blair Foundation

Medtronic

Mirum

NBIA Foundation

PTC Therapeutics

Raiden Science Foundation

Spastic Paraplegia Foundation

Zevra

Corporate Support Acknowledgement

The MDS-PAS Pediatric Movement Disorder Course is supported in part by unrestricted medical educational grants from the following supporters:

Abbott

AbbVie

Alexion

Elpida Therapeutics

Emalex Biosciences, Inc.

Medtronic

Mirum

PTC Therapeutics

Zevra

Foundation & Non-Profit Support Acknowledgement

The MDS-PAS Pediatric Movement Disorder Course is supported in supported in part by the following foundations and non-profit organizations:

CureAP4

CureSPG4 Foundation

GNB1 Advocacy Group Inc

Movement Disorder Division, Massachusetts General Hospital

The Hospital for Sick Children (SickKids)

Translational Research Program Boston Children's Hospital

Accreditation and Credit Designation Statement

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The International Parkinson and Movement Disorder Society designates this activity for a maximum of 11.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.

FACULTY DISCLOSURE

All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available HERE. All relevant financial relationships have been mitigated in advance of this program.

SATISFACTORY COMPLETION

Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.

CONTENT VALIDITY STATMENT

All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.